Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

TECH

Bio-Techne Corp

Dec 08 • 04:00PM ET

68.31

Dollar change +0.26
Percentage change 0.38	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	S&P 500	P/E	44.81	EPS (ttm)	1.52	Insider Own	1.02%	Shs Outstand	157.64M	Perf Week	5.79%
Market Cap	10.80B	Forward P/E	31.21	EPS next Y	2.19	Insider Trans	-5.24%	Shs Float	156.54M	Perf Month	16.43%
Income	246.65M	PEG	4.72	EPS next Q	0.41	Inst Own	97.32%	Short Float / Ratio	1.85% / 2.57	Perf Quarter	-4.63%
Sales	1.14B	P/S	9.44	EPS this Y	-6.81%	Inst Trans	2.02%	Short Interest	2.90M	Perf Half Y	-12.90%
Book/sh	12.62	P/B	5.41	EPS next Y	18.01%	ROA	9.66%	Target Price	77.87	Perf Year	-15.32%
Cash/sh	0.94	P/C	72.67	EPS next 5Y	9.50%	ROE	13.16%	52W Range	51.79 - 89.91	Perf YTD	-17.58%
Dividend	0.25	P/FCF	50.15	EPS past 5Y	16.30%	ROI	9.73%	52W High	-24.02%	Beta	1.25
Dividend %	0.37%	Quick Ratio	3.17	Sales past 5Y	12.42%	Gross Margin	67.78%	52W Low	31.90%	ATR	2.05
Employees	3050	Current Ratio	4.63	Sales Q/Q	2.70%	Oper. Margin	24.21%	RSI (14)	66.89	Volatility	2.86% 2.91%
Optionable	Yes	Debt/Eq	0.28	EPS Q/Q	-42.98%	Profit Margin	21.56%	Rel Volume	1.09	Prev Close	68.05
Shortable	Yes	LT Debt/Eq	0.27	Earnings	Oct 31 BMO	Payout	18.16%	Avg Volume	1.13M	Price	68.31
Recom	1.33	SMA20	9.50%	SMA50	8.15%	SMA200	-8.73%	Volume	1,229,200	Change	0.38%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-07-23	Initiated	UBS	Buy	$80
Aug-28-23	Initiated	William Blair	Outperform
Jan-10-23	Upgrade	Wells Fargo	Underweight → Equal Weight	$90
Dec-14-22	Initiated	Deutsche Bank	Buy	$100
Dec-12-22	Upgrade	Citigroup	Neutral → Buy	$81.25 → $100
Dec-07-22	Initiated	RBC Capital Mkts	Sector Perform	$89
Aug-25-22	Initiated	Credit Suisse	Outperform	$465
Apr-25-22	Downgrade	Wells Fargo	Equal Weight → Underweight	$370
Sep-15-21	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight	$600
Mar-08-21	Upgrade	Stephens	Equal-Weight → Overweight	$380 → $425
Feb-23-21	Upgrade	Stifel	Hold → Buy	$435
Jan-25-21	Reiterated	The Benchmark Company	Buy	$320 → $410
Nov-10-20	Initiated	KeyBanc Capital Markets	Sector Weight	$340
Sep-30-20	Initiated	Atlantic Equities	Overweight	$365
Jul-15-20	Downgrade	Stephens	Overweight → Equal-Weight
May-27-20	Downgrade	Stifel	Buy → Hold	$245 → $260
May-14-20	Initiated	The Benchmark Company	Buy	$290
Jan-08-20	Resumed	Stephens	Overweight	$250
Jan-08-20	Initiated	Wells Fargo	Equal Weight	$230
Jan-07-20	Initiated	Citigroup	Neutral	$235

Show Previous Ratings

Dec-01-23 01:32AM	Should You Hold Bio-Techne Corporation (TECH) For the Long Term? (Insider Monkey)
Nov-27-23 07:00AM	BIO-TECHNE TO PRESENT AT THE 6TH ANNUAL EVERCORE ISI HEALTHCONx CONFERENCE (PR Newswire)
Nov-13-23 07:00AM	BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES (PR Newswire)
Nov-02-23 07:00AM	ASURAGEN TO PRESENT NOVEL CLINICAL TESTING DATA AT AMP 2023 CONFERENCE (PR Newswire)
Nov-01-23 10:44AM	Bio-Techne Corporation (NASDAQ:TECH) Q1 2024 Earnings Call Transcript (Insider Monkey)
07:53AM	Loading…
Oct-31-23 07:53AM	Bio-Techne Corp (TECH) Reports 2% Organic Revenue Growth in Q1 FY2024 (GuruFocus.com)
07:27AM	Bio-Techne's quarterly profit misses estimates as biotech funding woes persist (Reuters)
06:30AM	BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS (PR Newswire)
06:30AM	BIO-TECHNE DECLARES DIVIDEND (PR Newswire)
Oct-25-23 03:42PM	3 AI Stock-Split Stocks to Buy Now (InvestorPlace)
09:00AM	LEADING RESEARCH INSTITUTES TO PRESENT NEW DATA USING LUNAPHORE'S COMET TECHNOLOGY AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) 38th ANNUAL MEETING (PR Newswire)
Oct-22-23 10:30AM	Bearish Bets: 3 Stocks You Definitely Should Think About Shorting This Week (TheStreet.com)
Oct-20-23 05:01AM	Various Headwinds Pressured Bio-Techne Corporation (TECH) Shares in Q3 (Insider Monkey)
Oct-19-23 07:00AM	BIO-TECHNE APPOINTS KIM KELDERMAN AS CHIEF EXECUTIVE OFFICER (PR Newswire)
Oct-16-23 07:00AM	BIO-TECHNE ACHIEVES ISO 13485 CERTIFICATION FOR ITS WALLINGFORD, CT MANUFACTURING FACILITY (PR Newswire)
07:00AM	Loading…
Oct-10-23 07:00AM	BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 31, 2023, TO ANNOUNCE FIRST QUARTER FISCAL 2024 FINANCIAL RESULTS (PR Newswire)
Oct-03-23 09:45AM	3 Healthcare Stocks to Keep an Eye On (Motley Fool)
Sep-28-23 06:00AM	DR. JORDAN LASER AWARDED AMP MERITORIOUS SERVICE AWARD (PR Newswire)
Sep-27-23 07:00AM	SCIENTISTS AT CE PHARM CONFERENCE DESCRIBE HOW Maurice AND MauriceFlex SYSTEMS TRANSFORM THEIR PROTEIN ANALYSIS (PR Newswire)
Sep-26-23 07:00AM	BIO-TECHNE INTEGRATES ITS MAURICE SYSTEM WITH THE THERMO SCIENTIFIC CHROMELEON CHROMATOGRAPHY DATA SYSTEM (PR Newswire)
Sep-25-23 07:00AM	BIO-TECHNE ISSUES 2023 CORPORATE SUSTAINABILITY REPORT (PR Newswire)
Sep-23-23 09:00AM	3 Healthcare Stocks That Should Be on Every Investors Radar This Fall (InvestorPlace)
Sep-19-23 02:00AM	Cizzle and Bio-Techne Announce Completion of Evaluation Programme for Detection of CIZ1B Using ProteinSimple Branded Simple Western Platform (PR Newswire)
Sep-18-23 07:32PM	Unveiling Bio-Techne (TECH)'s Value: Is It Really Priced Right? A Comprehensive Guide (GuruFocus.com)
10:14AM	Federal Reserve Likely to Maintain Rates Amid Mixed Economic Indicators (Investing.com)
Sep-08-23 11:35AM	Unveiling Bio-Techne (TECH)'s Value: Is It Really Priced Right? A Comprehensive Guide (GuruFocus.com)
Sep-06-23 12:04PM	Unveiling the Investment Potential of Bio-Techne Corp (TECH): A Comprehensive Analysis of ... (GuruFocus.com)
Aug-28-23 07:32PM	Unveiling Bio-Techne (TECH)'s Value: Is It Really Priced Right? A Comprehensive Guide (GuruFocus.com)
01:03PM	Unveiling the Investment Potential of Bio-Techne Corp (TECH): A Comprehensive Analysis of ... (GuruFocus.com)
10:47AM	Most Stocks in S&P 500 Are Rising Monday (Barrons.com)
07:00AM	Loading…
07:00AM	BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES (PR Newswire)
Aug-24-23 07:00AM	BIO-TECHNE ANNOUNCES 2023 INVESTOR DAY AND WEBCAST (PR Newswire)
Aug-21-23 01:05PM	Unveiling Bio-Techne Corp's Market Potential: A Comprehensive GF Score Analysis (GuruFocus.com)
Aug-18-23 07:32PM	Is Bio-Techne Corp (TECH) Modestly Undervalued? (GuruFocus.com)
Aug-15-23 07:00AM	BIO-TECHNE TO PRESENT AT THE UBS MEDTECH, TOOLS AND GENOMICS SUMMIT 2023 (PR Newswire)
Aug-14-23 07:00AM	BIO-TECHNE ENDS COLLABORATION PROGRAM WITH AKOYA TO AUTOMATE RNASCOPE ON THE PHENOCYCLER FUSION (PR Newswire)
Aug-08-23 12:36PM	Is Bio-Techne Corp (TECH) Modestly Undervalued? A Comprehensive Valuation Analysis (GuruFocus.com)
07:12AM	Bio-Techne misses revenue estimates on biotech funding crunch (Reuters)
06:30AM	BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS (PR Newswire)
06:30AM	BIO-TECHNE DECLARES DIVIDEND (PR Newswire)
Aug-05-23 09:49AM	Bio-Techne Corporation's (NASDAQ:TECH) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong? (Simply Wall St.)
Jul-28-23 05:14PM	3 Biotech Stocks to Buy Before the Breakout (InvestorPlace)
Jul-13-23 07:00AM	BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 8, 2023, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2023 FINANCIAL RESULTS (PR Newswire)
Jul-10-23 07:00AM	BIO-TECHNE COMPLETES LUNAPHORE ACQUISITION (PR Newswire)
Jun-22-23 02:55PM	Bio-Techne Acquires Lunaphore to Strengthen Spatial Biology Capabilities (Exec Edge)
12:57PM	Bio-Techne's Acquisition of Lunaphore Expands Its Spatial Biology Offerings (Benzinga)
08:00AM	Lunaphore to Get Acquired by Bio-Techne (Business Wire)
08:00AM	BIO-TECHNE TO ACQUIRE LUNAPHORE (PR Newswire)
07:38AM	Market Digest: TECH, THO (Argus Research)
07:38AM	Analyst Report: Bio-Techne Corp (Argus Research)
Jun-16-23 11:23AM	Calculating The Fair Value Of Bio-Techne Corporation (NASDAQ:TECH) (Simply Wall St.)
Jun-01-23 07:00AM	BIO-TECHNE SUCCESSFUL ON CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC (PR Newswire)
May-29-23 06:47AM	Should You Hold Bio-Techne Corp. (TECH)? (Insider Monkey)
May-25-23 07:00AM	BIO-TECHNE TO PRESENT AT THE 2023 JEFFERIES HEALTHCARE CONFERENCE (PR Newswire)
May-18-23 07:00AM	EXOSOME DIAGNOSTICS RELEASES INTERIM RESULTS FROM CLINICAL STUDY OF PROSTATE CANCER RISK TEST (PR Newswire)
May-16-23 10:45AM	Those who invested in Bio-Techne (NASDAQ:TECH) five years ago are up 118% (Simply Wall St.)
07:00AM	BIO-TECHNE COMMERCIALIZES RNASCOPE SPATIAL BIOLOGY WORKFLOW FOR THE STANDARD BIOTOOLS HYPERION IMAGING SYSTEM (PR Newswire)
May-12-23 09:07AM	BIO-TECHNE TO PRESENT AT THE 2023 RBC CAPITAL MARKETS GLOBAL HEALTHCARE CONFERENCE (PR Newswire)
May-10-23 07:00AM	BIO-TECHNE ANNOUNCES LAUNCH OF KAPPA AND LAMBDA RNAscope ISH PROBES AS ANALYTE SPECIFIC REAGENTS (ASRs) FOR THE DETECTION OF IMMUNOGLOBULIN KAPPA AND LAMBDA LIGHT CHAINS mRNA (PR Newswire)
May-03-23 06:30AM	BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS (PR Newswire) +7.21%
06:30AM	BIO-TECHNE DECLARES DIVIDEND (PR Newswire)
May-02-23 07:00AM	BIO-TECHNE TO PRESENT AT THE BofA SECURITIES 2023 HEALTH CARE CONFERENCE (PR Newswire)
06:40AM	Heres Why Bio-Techne Corporation (TECH) Declined in Q1 (Insider Monkey)
Apr-19-23 07:22PM	7 Biotech Stocks That Could Cure Your Portfolio Woes (InvestorPlace)
Apr-17-23 07:00AM	BIO-TECHNE AND LUNAPHORE ESTABLISH STRATEGIC PARTNERSHIP TO DEVELOP THE FIRST FULLY AUTOMATED SAME-SLIDE SPATIAL MULTIOMICS SOLUTION (PR Newswire)
Apr-13-23 07:00AM	BIO-TECHNE TO SHOWCASE INNOVATIVE CANCER RESEARCH, CELL THERAPY AND MANUFACTURING TOOLS AT AACR 2023 CONFERENCE (PR Newswire)
Apr-12-23 07:00AM	BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 3, 2023, TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTS (PR Newswire)
Apr-11-23 06:24AM	At US$75.19, Is Bio-Techne Corporation (NASDAQ:TECH) Worth Looking At Closely? (Simply Wall St.)
Apr-05-23 07:00AM	BIO-TECHNE CELEBRATES MILESTONE WITH MORE THAN 1,000 ELLA INSTRUMENTS NOW IN OPERATION (PR Newswire)
Apr-03-23 07:00AM	BIO-TECHNE COMPLETES INVESTMENT IN WILSON WOLF MANUFACTURING (PR Newswire)
Mar-31-23 10:36AM	The Argus Mid-Cap Model Portfolio (Argus Research)
Mar-27-23 06:45AM	Is Now The Time To Put Bio-Techne (NASDAQ:TECH) On Your Watchlist? (Simply Wall St.)
Mar-17-23 07:15AM	Analyst Report: Bio-Techne Corp (Argus Research)
07:00AM	Market Digest: ADBE, EIX, BBWI, TECH (Argus Research)
Mar-15-23 07:00AM	BIO-TECHNE ANNOUNCES COMPLETION OF CELL AND GENE THERAPY CATAPULT PROCESS ANALYTICAL TECHNOLOGY (PAT) CONSORTIUM (PR Newswire)
Mar-10-23 07:00AM	BIO-TECHNE TO PRESENT AT THE BARCLAYS GLOBAL HEALTHCARE CONFERENCE (PR Newswire)
Mar-01-23 07:00AM	BIO-TECHNE ANNOUNCES INVESTMENT IN WILSON WOLF (PR Newswire)
Feb-28-23 09:58AM	BIO-TECHNE TO PRESENT AT THE COWEN 43rd ANNUAL HEALTH CARE CONFERENCE (PR Newswire)
Feb-26-23 08:39AM	Is Weakness In Bio-Techne Corporation (NASDAQ:TECH) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects? (Simply Wall St.)
Feb-24-23 08:40AM	ExoDx PROSTATE TEST GRANTED EXPANDED COVERAGE BY MEDICARE (PR Newswire)
Feb-22-23 07:00AM	BIO-TECHNE TO PRESENT AT THE CITI 2023 HEALTHCARE SERVICES, MEDTECH, TOOLS & HCIT CONFERENCE (PR Newswire)
Feb-14-23 07:00AM	BIO-TECHNE AND CELL SIGNALING TECHNOLOGY ANNOUNCE PARTNERSHIP TO VALIDATE SIMPLE WESTERN ANTIBODIES (PR Newswire)
Feb-06-23 02:06AM	Bio-Techne Corporation (NASDAQ:TECH) Q2 2023 Earnings Call Transcript (Insider Monkey)
Feb-05-23 07:06AM	Bio-Techne Second Quarter 2023 Earnings: Misses Expectations (Simply Wall St.)
Feb-02-23 06:30AM	BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS (PR Newswire)
06:30AM	BIO-TECHNE DECLARES DIVIDEND (PR Newswire)
Jan-31-23 07:00AM	BIO-TECHNE ANNOUNCES RETIREMENT, APPOINTMENT OF GENERAL COUNSEL (PR Newswire)
Jan-26-23 07:00AM	BIO-TECHNE LAUNCHES THE MauriceFlex SYSTEM, ADDING cIEF FRACTIONATION CAPABILITY TO THE GOLD STANDARD MAURICE ASSAYS (PR Newswire)
Jan-24-23 03:25PM	Top Healthcare Stocks (Investopedia)
Jan-17-23 07:00AM	BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 2, 2023, TO ANNOUNCE SECOND QUARTER 2023 FINANCIAL RESULTS (PR Newswire)
Jan-10-23 07:00AM	BIO-TECHNE LAUNCHES RNASCOPE PLUS ASSAY TO ADVANCE GENE THERAPY DEVELOPMENT (PR Newswire)
Jan-07-23 09:09AM	A Look At The Fair Value Of Bio-Techne Corporation (NASDAQ:TECH) (Simply Wall St.)
Dec-22-22 11:21AM	Do You Think Bio-Techne Corporation (TECH) Has a Positive Long-Term Trend? (Insider Monkey)
Dec-21-22 07:00AM	BIO-TECHNE TO PRESENT AT THE 41st ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE (PR Newswire)
Dec-19-22 08:43AM	Should You Invest in Bio-Techne Corporation (TECH)? (Insider Monkey)
Dec-09-22 05:42PM	Our 7 Top Biotech Stock Picks for 2023 (InvestorPlace)
Dec-07-22 09:01AM	Bio-Techne's (NASDAQ:TECH) investors will be pleased with their impressive 160% return over the last five years (Simply Wall St.)
Dec-05-22 07:00AM	BIO-TECHNE RELEASES MITOBRILLIANT FLUORESCENT DYES, PROVIDING A NEXT-GENERATION TOOL FOR IMAGING MITOCHONDRIA IN LIVE AND FIXED CELLS (PR Newswire)
Dec-01-22 07:00AM	Bio-Techne and Oxford Nanopore Technologies partner to bring innovative reproductive health and carrier screening solutions to the market (PR Newswire)
Nov-28-22 12:31PM	Should You Invest in Bio-Techne Corporation (TECH)? (Insider Monkey)

Bio-Techne Corp. engages in the development, manufacture and sale of biotechnology reagents and instruments for the research and clinical diagnostic markets. It operates through the Protein Sciences, and Diagnostics and Genomics segments. The Protein Sciences segment develops and manufactures purified proteins, and reagent solutions. The Diagnostics and Genomics segment develops and manufactures diagnostic products. The company was founded in 1976 and is headquartered in Minneapolis, MN.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Nusse Roeland	Director	Aug 30	Option Exercise	22.40	32,000	716,800	60,811	Sep 01 04:06 PM
Nusse Roeland	Director	Aug 30	Sale	80.32	8,939	717,959	51,872	Sep 01 04:06 PM
Kelderman Kim	Pres. Diagnostics & Genom	Aug 24	Option Exercise	47.60	2,100	99,960	21,225	Aug 28 04:19 PM
Kummeth Charles R.	Chief Executive Officer	Aug 15	Option Exercise	0.00	17,632	0	1,286,944	Aug 17 04:14 PM
Kummeth Charles R.	Chief Executive Officer	Aug 05	Option Exercise	0.00	51,516	0	1,310,282	Aug 08 05:31 PM
Hippel James	CFO	Aug 05	Option Exercise	0.00	12,876	0	63,896	Aug 08 05:29 PM
Kelderman Kim	Pres. Diagnostics & Genom	Aug 05	Option Exercise	0.00	8,060	0	23,264	Aug 08 05:28 PM
Kummeth Charles R.	Chief Executive Officer	Jul 21	Sale	88.36	80,000	7,069,024	1,258,766	Jul 25 05:27 PM
Kummeth Charles R.	Chief Executive Officer	Jun 30	Option Exercise	26.65	616,676	16,434,415	1,729,493	Jul 05 06:38 PM
Kummeth Charles R.	Chief Executive Officer	Jun 07	Sale	83.00	322	26,726	1,112,817	Jun 09 04:07 PM
HIGGINS JOHN L	Director	Apr 28	Option Exercise	21.85	16,000	349,600	39,360	May 02 04:49 PM
Kummeth Charles R.	Chief Executive Officer	Jan 04	Option Exercise	26.65	407,364	10,856,251	1,368,976	Jan 06 04:37 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

TECH

Bio-Techne Corp

Upgrade your FINVIZ experience